We invest in every facet of ALS research so that scientific progress can advance faster than the disease.
Breaking barriers
to ALS research, accelerating progress
We’re changing the future of ALS research by breaking down barriers and investing in science that moves faster than this devastating disease. Our model is accelerating the path to effective treatments and inspiring hope for everyone affected by ALS.
The power of focus
Our new Target ALS Research Cores are comprised of a network of academic centers and contract research organizations that provide needed tools and resources to scientists. By supporting researchers with essential resources, we reduce barriers to advancement and accelerate the path to breakthroughs—for a future with a cure.
Impact by the numbers
Copy briefly sharing how Target ALS has made significant progress in little time which has resulted in tangible results including the following stats
675
Research grants funded
$80M
Invested in ALS research
53%
of research consortia we’ve funded has led to drug discovery
Powering science
Copy briefly sharing how Target ALS has made significant progress in little time which has resulted in tangible results including the following stats
We provide scientists with access to critical ALS research tools and resources with no strings attached.
We are reshaping research and how ALS is understood with studies powered by our ALS Global Research Initiative (AGRI).
Our grantmaking process:
Optional description goes here and lorem ipsum dolor sit amet consectetur. Dui etiam mi vel vel laoreet sollicitudin tellus ultrices. Malesuada amet viverra sed ultrices mauris tempus tempor eget.
Our mission
Optional secondary text of up to 150 characters goes here. <br> Lorem ipsum dolor sit amet consecetur adipiscing elit. Lorem ipsum dolor sit.
Our approach
Optional secondary text of up to 150 characters goes here. Lorem ipsum dolor sit amet consecetur adipiscing elit. Lorem ipsum dolor sit.
Our impact
Optional secondary text of up to 150 characters goes here. Lorem ipsum dolor sit amet consecetur adipiscing elit. Lorem ipsum dolor sit.
Global Impact
Optional secondary text goes here up to 160 characters. Lorem ipsum dolor sit amet consectetur. Pretium volutpat nec turpis cursus id malesuada urna.
Title text goes here and here
OCTOBER 12, 2025
Optional subtext goes here and here. Massa consectetur quis blandit urna imperdiet sit magna diam posuere. Faucibus quis mattis turpis aenean.
Title text goes here and here
NOVEMBER 12, 2025
Optional subtext goes here and here. Massa consectetur quis blandit urna imperdiet sit magna diam posuere. Faucibus quis mattis turpis aenean.
Featured stories
Optional description goes here vivamus integer non suscipit taciti mus etiam at primis tempor sagittis sit, euismod libero facilisi aptent elementum felis blandit cursus gravida sociis erat ante, eleifend lectus nullam.#
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s,
“Lorem ipsum dolor sit amet, highlighted_textconsectetur adipiscing elit. Netus ornare dolor maece. Ut enim ad minim veniam, quis nostrud exercitation.”
consectetur adipiscing elit
firstname lastname firstname lastname firstname lastname firstname lastname firstname lastname firstname lastname firstname lastname firstname lastnameqwerty test
“Lorem ipsum dolor sit amet, consectetur adipiscing elit. Netus ornare dolor maece. Ut enim ad minim veniam, quis nostrud exercitation.”
Powering science
Copy briefly sharing how Target ALS has made significant progress in little time which has resulted in tangible results including the following stats
Join our community
Sign up for important updates from Target ALS. Sign up for important updates from Target ALS.Sign up for important updates from Target ALS.Sign up for important updates from Target ALS.
Meet our founder
We were founded by Dan Doctoroff, former NYC Deputy Mayor for Economic Development and Rebuilding under Mayor Michael Bloomberg. Dan lost both his father and uncle to ALS.
As deputy mayor, Dan used his talents to revitalize one of the world’s greatest cities following the 9/11 terror attacks. His collaborative, creative approach helped to drive the development of Hudson Yards, The High Line, Brooklyn Bridge Park, and ultimately transform the city.
Dan’s focus on collaboration also helped inspire a foundation for Target ALS, enabling us to achieve incredible breakthroughs by bringing together the scientific community like never before.
Featured stories
Optional description goes here vivamus integer non suscipit taciti mus etiam at primis tempor sagittis sit, euismod libero facilisi aptent elementum felis blandit.
3 up card by grant status
Optional description goes here vivamus integer non suscipit taciti mus etiam at primis tempor sagittis sit, euismod libero facilisi aptent elementum felis blandit.
